December 2, 2008

SHARE

Comments

My biotech company, GenoMed (OTC Pink Sheets: GMED) has had encouraging results treating West Nile virus encephalitis since 2003: 81% treatment success rate in people (22 of 27), 75% in horses, and 50% in birds. Our first 8 WNV patients were published in a peer-reviewed medical journal in 2004. We’re eager to see if our approach works again this year. Anybody who wants to download our WNV trial protocol can do so for free at any time by clicking on the "West Nile trial" link on our company’s homepage at www.genomed.com.

Dave Moskowitz MD
CEO & Chief Medical Officer
GenoMed, Inc.
www.genomed.com

alison b

Can you give us a summary of what the WNV treatment is that has been so successful?

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.